Teloxantrone
Alternative Names: CI 937; DUP 937; Moxantrazole; NSC 355644; PD 113309Latest Information Update: 24 Sep 2002
At a glance
- Originator Pfizer
- Class Cytostatics
- Mechanism of Action DNA inhibitors; Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 24 Sep 2002 Discontinued - Phase-I for Cancer in Canada (unspecified route)
- 24 Sep 2002 Discontinued - Phase-I for Cancer in USA (unspecified route)
- 12 Jul 2000 Profile reviewed but no significant changes made